Login / Signup

In Search of Novel SGLT2 Inhibitors by High-throughput Virtual Screening.

Abhijit DebnathShalini SharmaRupa MazumderDr Avijit MazumderRajesh Kumar SinghAnkit KumarArpita DuaPriya SinghalArvind KumarGurvinder Singh
Published in: Current drug discovery technologies (2023)
The identified molecules could manage T2DM effectively by inhibiting SGLT2, providing a promising avenue for future therapeutic strategies.
Keyphrases
  • high throughput
  • signaling pathway
  • current status
  • single cell
  • type diabetes
  • adipose tissue